Johnson & Johnson and U.S. Sign Potential COVID-19 Vaccine Deal Worth $1 Billion
The United States has signed a contract worth just over $1 billion with Johnson & Johnson for 100 million doses of a potential Covid-19 vaccine.
KATC.com reports the U.S. currently has contracts with "several pharmaceutical companies as part of Operation Warp Speed", a program designed to develop, test and distribute a COVID-19 vaccine as quickly as possible once available.
The deal with Johnson & Johnson also allows for an addition 200 million doses of a COVID-19 vaccine to be purchased.
From KATC.com -
"Johnson & Johnson’s vaccine, developed by subsidiary Janssen Pharmaceutical Companies, has shown positive preclinical results. Testing of their vaccine is currently underway with human trials in the United States and Belgium."